David S. Silberstein insider trades

Open-market stock purchases and sales by David S. Silberstein, Director at Lantern Pharma Inc, from SEC Form 4 filings since Jun 15, 2020.

Recent trades

DateStockTradeValue
Jan 9, 2026LTRN Lantern Pharma IncBought (not open market)—
Jan 9, 2026LTRN Lantern Pharma IncBought (not open market)—

Companies traded

  • LTRN Lantern Pharma Inc: other filings, last Jan 9, 2026

Get free alerts when David S. Silberstein files a new trade →